Liberator Medical Holdings, Inc. (OTCBB:LBMH) Takes a Bigger Step Down
After hitting a new three-year high last week, Liberator Medical Holdings, Inc. (OTCBB:LBMH) seemed to run out of breath after straddling the $2.40 mark. The following four sessions saw LBMH drop about 10% and retreat to its last close at $2.21 per share. Yesterday’s drop was the biggest percentile red day for the company over the last month.
Liberator have been quiet on the PR front over the last few days. However, the company did publish an official filing that suggests LBMH is applying for listing of its common stock on the New York Stock Exchange. The filing in question is a Form 8-A12B, or a Registration for Listing of a Security on a National Exchange Form. The form lists “NYSE MKT LLC” as the exchange on which the securities are to be registered and the securities themselves comprise LBMH common stock.
It is perhaps a little strange that the filing was made public last Friday and there is no accompanying press release or formal announcement on part of the company, but then again, Liberator are not known for spamming their news feed with every bit of information that comes up and may be waiting for approval or further developments before making the announcement.
Despite the appearance of the filing, the price marched down over the last four sessions, with a minor interruption on Friday, when LBMH closed nearly flat. The retrace could be a natural reaction of the price that tested the $2.40 level once before and then retreated 40 cents lower before recovering.
Other tickers that moved in double digits yesterday include diaDexus, Inc. (OTCMKTS:DDXS) who crashed over 50% on a news release concerning unmet trial results. Nutranomics, Inc., f/k/a Buka Ventures, Inc. (OTCBB:NNRX) put on 18% and closed green at $0.62 per share.